863976-37-8

Basic information

• Product Name: (4R)-4-hydroxy-1-[(2’-methyl-1,1‘-biphenyl-4yl)-carbonyl]-L-proline
• Synonyms: (4R)-4-hydroxy-1-[(2’-methyl-1,1‘-biphenyl-4yl)-carbonyl]-L-proline
• CAS NO: 863976-37-8
• Molecular Weight: 325.364
• Mol File: 863976-37-8.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: (4R)-4-hydroxy-1-[(2’-methyl-1,1‘-biphenyl-4yl)-carbonyl]-L-proline(CAS DataBase Reference)
• NIST Chemistry Reference: (4R)-4-hydroxy-1-[(2’-methyl-1,1‘-biphenyl-4yl)-carbonyl]-L-proline(863976-37-8)
• EPA Substance Registry System: (4R)-4-hydroxy-1-[(2’-methyl-1,1‘-biphenyl-4yl)-carbonyl]-L-proline(863976-37-8)

Safety Data

• Hazardous Substances Data: 863976-37-8(Hazardous Substances Data)

Upstream product

• 193153-28-5 4-(2-methylphenyl)benzoic acid chloride 
• 51-35-4 4R-4-hydroxyproline 
• 5748-43-6 4-(2-methylphenyl)benzoic acid 
• 16419-60-6 2-Methylphenylboronic acid 

Downstream Products

• 863976-38-9 1-(2’-methyl-1,1’-biphenyl-4-yl)carbonyl-4-oxo-L-proline 

Relevant articles and documents

OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO IMPLANTATION AND PREVENTING MISCARRIAGE

The disclosure provides compositions and methods for the use of oxytocin antagonists, such as substituted pyrrolidin-3-one oxime derivatives of formula (I), among other compounds, in the treatment of subjects undergoing embryo transfer therapy. The compos

OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO IMPLANTATION AND PREVENTING MISCARRIAGE

The invention provides compositions and methods for the use of oxytocin antagonists, such as substituted pyrrolidin-3-one oxime derivatives, among other compounds, in the treatment of subjects undergoing embryo transfer therapy. The compositions and metho

PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAGONISTS

The present invention relates to a compound of formula (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methy19243-yloxime, and/or an active metabolite thereof having antagonist action at the oxytocin receptor and/or